The Differential Contribution of the Innate Immune System to a Good Pathological Response in the Breast and Axillary Lymph Nodes Induced by Neoadjuvant Chemotherapy in Women with Large and Locally Advanced Breast Cancers

Table 14

Effect of NAC on blood DC levels in women with LLABCs.

Pathological responders	DC baseline levels (%)
	value
GPRs + PPRs	1.34 ± 0.30
GPRs + PPRs versus HFDs	NS
GPRs	1.64 ± 0.25
GPRs versus HFD	NS
PPRs	1.29 ± 0.25
PPRs versus HFDs	NS
Pathological responders	DC post-NAC levels (%)
	value
GPRs	3.24 ± 1.62
GPRs versus HFDs	0.024
PPRs	2.17 ± 0.5
PPRs versus HFDs	NS

NAC: neoadjuvant chemotherapy; LLABCs: large and locally advanced breast cancers; GPRs: good pathological responders (pCR or ≥90% reduction of invasive disease); PPRs: poor pathological responders (no response or <90% reduction of invasive disease); HFDs: healthy female donors; NS: nonsignificant; statistically significant.